ClearSight Therapeutics
2 known investors
ClearSight Therapeutics develops over-the-counter ophthalmic products for common eye conditions such as dry eye, contact lens dryness, and conjunctivitis, working within FDA OTC monograph pathways. Its formulations aim to support ocular surface lubrication and moisture retention for consumers experiencing eye discomfort.
Founders & leadership
PS
Patrick SmaleCofounder & CEO
SA
Suchismita AcharyaCofounder & Clinical Development Lead
NJ
Nuria JimenezChief Scientific Officer
Investors · 2
Frequently asked questions
- What does ClearSight Therapeutics do?
- ClearSight Therapeutics develops over-the-counter ophthalmic products for common eye conditions such as dry eye, contact lens dryness, and conjunctivitis, working within FDA OTC monograph pathways. Its formulations aim to support ocular surface lubrication and moisture retention for consumers experiencing eye discomfort.
- Who founded ClearSight Therapeutics?
- ClearSight Therapeutics was founded by Patrick Smale, Suchismita Acharya.
- Who are ClearSight Therapeutics's investors?
- ClearSight Therapeutics's investors include Health Wildcatters, Capital Factory.